Clinical trial
CDDO to Treat Solid Tumors and Lymphomas
NCT00322140 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00322140 |
|---|---|
| Title | CDDO to Treat Solid Tumors and Lymphomas |
| Official title | Phase I Study of CDDO in Solid Tumors and Lymphomas |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Solid Tumors, Lymphoma |
| Intervention type | Drug |
| Interventions | CDDO |
| Enrollment | 7 |
| Start date | May 1, 2006 |
| Primary completion | Jan 14, 2008 |
| Completion | Jan 14, 2008 |
| First posted | May 5, 2006 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: